A brief summary of the CMS Coding 2021 – AAOA Zoomcast Series: Just In Time Content for AAOA Members, Part II. Written by Christie DeMason MD, FAAOA. Panelists: James Connolly, MD; Ayesha Khalid, MD, MBA; Nalin Patel, MD; Robert Stachler,…
This summary is intended to provide practicing Otolaryngologists a guide to resuming safe allergy care in the era of COVID-19 pandemic.
The impact of COVID-19 has been an unprecedented for modern healthcare, resulting in disruption of most elective care, including the practice of allergy. Many otolaryngology and allergy practices have suspended skin testing and immunotherapy for a period of months. With recent downward trends of the COVID-19 curve, practices are beginning to plan for re-entry to clinical practice. There is limited scientific data and expert opinion on how to return to practice. The purpose of this document is to summarize practical clinical considerations related to restarting allergy patient care once COVID-19 restrictions allow for elective care. It is recommended that you continue to monitor incidence and exposure in your region.
View and download the Resuming SCIT During COVID-19 Pandemic Resource here.